Several highly anticipated PDUFA decisions are approaching..👇 Abeona Therapeutics ($Abeona Therapeutics(ABEO.US)$) Asset: Pz-cel (prademagene zamikeracel) PDUFA Date: May 25, 2024 Indication: Recessive dystrophic epidermolysis bullosa (RDEB) Technology: Autologous cell therapy, treatment uses gene transfer to deliver COL7A1 genes into an RDEB patient’s own skin cells then transplanting them back to the patient. Rocket Pharmaceuticals ($Rocket Pharmaceuticals(RCKT.US)$)...
The appointment of Robert W. Azelby, with his extensive experience and track record in building successful biotech companies, is seen as a valuable addition to Autolus's Board as the company moves closer to commercializing its first product.
The significant increase in Autolus Therapeutics' share price and revenue growth has caught the market's attention, signalling optimism. However, despite recent positive returns, the company's long-term loss requires cautious investment consideration.
Dr. Christian Itin, CEO of Autolus, expressed optimism about Leiderman's appointment citing her vast financial, transaction, and operational experience. He also shared the company's anticipation to transition from a development stage to a commercial entity.
Why Join Us? Pre-market Magic: Wanna know the insider scoop before the market opens? Our talented crew will give you the lowdown on pre-market movements, giving you a sneak peek into the thrill of investing! FDA Calendar Know-how: Confused about FDA approval processes? Fear not! Our FDA Calendar will turn you into a pharma whiz, keeping you in the loop with crucial timings! Money Trail: Curious about where the funds are flowing? The Fundraising Tracker '23 is here to spill the beans, ...
Autolus Therapeutics股票讨论区
I love when swings work right away
Looking good for a swing
Upcoming Cell & Gene Therapy PDUFA’s in 2024
Abeona Therapeutics ($Abeona Therapeutics(ABEO.US)$ )
Asset: Pz-cel (prademagene zamikeracel)
PDUFA Date: May 25, 2024
Indication: Recessive dystrophic epidermolysis bullosa (RDEB)
Technology: Autologous cell therapy, treatment uses gene transfer to deliver COL7A1 genes into an RDEB patient’s own skin cells then transplanting them back to the patient.
Rocket Pharmaceuticals ($Rocket Pharmaceuticals(RCKT.US)$ )...
Also on this week's watchlist
Healthcare
Pre-market Magic: Wanna know the insider scoop before the market opens? Our talented crew will give you the lowdown on pre-market movements, giving you a sneak peek into the thrill of investing!
FDA Calendar Know-how: Confused about FDA approval processes? Fear not! Our FDA Calendar will turn you into a pharma whiz, keeping you in the loop with crucial timings!
Money Trail: Curious about where the funds are flowing? The Fundraising Tracker '23 is here to spill the beans, ...
Daily alerts recap ⚡️ 7/26
Todays top stocks to look into
$Autolus Therapeutics(AUTL.US)$
$Bright Minds Biosciences(DRUG.US)$
暂无评论